JPMorgan's stock price outlook weakens, third-quarter performance falls short of Wall Street's expectations
Coinpedia
52m ago
Ai Focus
JPMorgan Chase's third-quarter performance fell short of expectations, with both revenue and earnings per share below Wall Street's forecasts. The slowdown in its investment banking business has also raised concerns about the sustainability of growth. Despite solid performance in trading and net interest income, the stock price has retreated to a key support range, with $320 to $325 becoming the focus of market attention.
Helpful
No.Help

JPMorgan's stock price came under pressure after third-quarter earnings and revenue fell short of analyst expectations, and the market became more cautious about its short-term prospects. Although net profit increased year-over-year, both earnings per share and revenue failed to meet market consensus. The slowdown in its investment banking business also raised doubts about the sustainability of growth. JPMorgan's trading business performed better, but this was not enough to dispel concerns about a slowdown in customer activity. As the stock price approaches a key technical support level, investors are weighing the bank's fundamental resilience against the risk of weaker profit momentum in the coming quarters.

JPMorgan's performance falling short of expectations raises new concerns

An investment of $658 million resulted in losses, putting additional pressure on performance. More importantly, at a time when profits fell short of expectations, some of the bank's strongest businesses also showed signs of slowing down compared to the previous quarter. For investors, the concern is not just that JPMorgan did not meet expectations, but whether the bank will be able to continue to deliver the growth that Wall Street has factored into its stock price, especially against the backdrop of changing market conditions and corporate activities.

Slowing down of trading activities puts pressure on investment banking business

JPMorgan's investment banking fees increased by 14% year-on-year, but decreased by 8% compared to the second quarter. CEO Jamie Dimon stated that customer activity in investment banking and market business has cooled down from the strong levels of the previous quarter. Such a sequential slowdown is important because mergers and acquisitions (M&A) and initial public offerings (IPOs) can bring considerable revenue to large banks. If companies postpone their listing or financing plans, investment banking revenues may face further pressure.

However, JPMorgan Chase's market business provided some support, and driven by volatility, revenue increased by 15% year-on-year. The retail banking business also maintained its resilience, with net interest income growing by 6% to $24.7 billion, and average loans increasing by 10%. Nevertheless, these strong performances cannot eliminate the risk that a weakening investment banking business may drag down overall profit growth. Investors will be watching to see whether this slowdown is merely temporary or the beginning of a broader decline.

JPMorgan Stock Analysis: Can It Hold the 325 Dollar Support Level?

JPMorgan Chase's stock price has significantly fallen from its peak of nearly $370 in August and is currently attempting to stabilize in the range of $334 to $338. The recent rebound has not yet reversed the broader short-term weakness, and the stock price is still below the downward-moving moving average.

The support range of $320 to $325 is the most important level on the chart. This range coincides with a horizontal demand area and an upward trend line, forming a technical zone where buyers may attempt to hold the stock price.

If it effectively falls below $320 to $325, it will weaken the chart structure and put JPM under further downward pressure. If this support level holds, the stock price may attempt to rebound, but first it needs to break through the resistance around $338 to $342. If it manages to stay above this range, the stock price could open up space towards $350, however, a brief intraday rebound alone is not enough to negate the current bearish structure.

Can the seller push the price of JPM below its support level?

After third-quarter performance fell short of Wall Street's expectations and there were signs of cooling in its investment banking business, JPMorgan Chase's stock price is facing a severe test. Higher year-over-year profits and stronger trading revenues provide fundamental support for the stock price, but they have not alleviated market concerns about its growth trajectory. Technical factors also add to the risks: if the price falls below $320 to $325, the correction could deepen; if it manages to rebound above $338 to $342, short-term selling pressure is expected to ease. Until these two levels are clearly broken through, the risk remains on the downside.

Tip
$0
Like
0
Save
0
Views 12
WalletJYS reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
RBC Capital downgrades Sika AG to a 'Hold' rating
According to TipRanks, Dyson ranks 9,525th among 12,453 analysts. The current market consensus rating for Sika AG is 'moderate buy', with an average target price of 204.78 Swiss francs, representing a potential upside of 17.83% from the current level. Morgan Stanley also maintained a 'hold' rating for the stock in its report released on October 6th, with a target price of 187.00 Swiss francs.
Businessinsider
·2026-10-13 22:24:38
11
FTC and seven states accuse Martin Shkreli of violating a lifetime ban in the pharmaceutical industry and seek to prosecute him for contempt of court
The U.S. Federal Trade Commission ( FTC ) and seven states requested on Tuesday that a federal judge determine that Martin Shkreli, known as the "bad boy of the pharmaceutical industry," had contempted the court, alleging that he had "repeatedly and blatantly violated" a 2022 civil court order that barred him for life from entering the pharmaceutical industry. FTC and the states stated that since his release from prison in May 2022, Shkreli has publicly traded at least 60 pharmaceutical industry stocks and has made public comments about the business and management of several pharmaceutical companies.
CNBC
·2026-10-13 22:24:36
12
Why Has Bitcoin's Latest Rebound Stopped Around $84,000?
On October 13, Bitcoin briefly rebounded to around $84,000, but weak demand for spot Bitcoin in the United States and a dense of sell orders around that price level limited further gains. At the same time, a sharp decline in the South Korean stock market, as well as the prospects for U.S. inflation data and Federal Reserve interest rate decisions, also kept the market cautious.
crypto.news
·2026-10-13 22:24:33
11
Arizona region MLS brokers can access HouseCanary's Google property listing program
HouseCanary indicates that it has signed a data agreement with Arizona Regional MLS, which serves most areas of Arizona and has over 38,000 subscribed users. According to this agreement, the properties for sale offered by ARMLS brokerage companies that choose to join will be eligible to appear in the search results on Google.
PR Newswire
·2026-10-13 22:24:32
11
Goldman Sachs and JPMorgan Chase refuse to underwrite $3.7 billion in AI chip loans, Volta financing costs rise above 11%
According to Bloomberg, PitchBook LCD and IFR, JPMorgan Chase and Goldman Sachs jointly led a financing of approximately $5 billion for Volta Infrastructure Holdings. However, they only provided underwriting guarantees for loans related to the $1.3 billion lease portion, while adopting a "best efforts" approach for the $3.7 billion GPU loans. The yield on this transaction upon maturity ranges from 11.21% to 11.75%, which is higher than that of some similar GPU financings. This reflects that banks are still involved in AI infrastructure financing, but they have become more cautious regarding the risks associated with chip loans.
Wallstreetcn
·2026-10-13 22:24:30
11
View More